Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 41.3% in the afternoon session after the ...

Inspire Medical Systems (NYSE:INSP) saw its stock plunge 27% following disappointing quarterly results and a lowered outlook, which led four major Wall Street firms to downgrade the shares. Truist ...

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

Q2 2025 Earnings Call Transcript August 4, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $0 ...

Investing.com -- Inspire Medical Systems (NYSE: INSP) stock plunged 27% after the company’s disappointing quarterly results and guidance prompted four Wall Street firms to downgrade the shares.

Hormones play a significant role in weight management, influencing appetite, metabolism, and fat storage. Silvia went to Inspire Medical to learn more about what we can do to have our hormones working ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Inspire Medical Systems targets $940M-$955M revenue in 2025 with Inspire V launch Feb. 10, 2025 11:55 PM ET Inspire Medical Systems, Inc. (INSP) Stock AI-Generated Earnings Calls Insights 1 Comment ...